Media coverage
17
Media coverage
Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet Spoke.com Country/Territory United States Date 14/01/23 URL https://www.spoke.com/press_releases/63c27a66f0f23e3cc2002962 Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet Health Technology Net Country/Territory United States Date 14/01/23 URL healthtechnologynet.com/2023/01/14/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet KRON4 Country/Territory United States Date 14/01/23 URL https://www.kron4.com/news/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet KFOR.com Country/Territory United States Date 14/01/23 URL https://kfor.com/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet WREG Country/Territory United States Date 14/01/23 URL https://wreg.com/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet Fox 16 Country/Territory United States Date 14/01/23 URL https://www.fox16.com/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet WANE-TV Country/Territory United States Date 14/01/23 URL https://www.wane.com/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet VB Profiles Country/Territory United States Date 14/01/23 URL https://www.vbprofiles.com/press_releases/63c27a6c623ac27a01ad5775 Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet WKBN 27 First News Country/Territory United States Date 14/01/23 URL https://www.wkbn.com/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet KXAN Country/Territory United States Date 14/01/23 URL https://www.kxan.com/news/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Media name/outlet Life Care News Country/Territory India Date 14/01/23 URL https://lifecarenews.in/arcutis-presents-new-phase-2-long-term-data-showing/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast ... Media name/outlet EIN Presswire Country/Territory United States Date 14/01/23 URL https://www.einpresswire.com/article/611305599/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet WGNO Country/Territory United States Date 14/01/23 URL https://wgno.com/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet 8 News Now Country/Territory United States Date 14/01/23 URL https://www.8newsnow.com/news/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet Everything Lubbock Country/Territory United States Date 14/01/23 URL https://www.everythinglubbock.com/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet MyPanhandle.com Country/Territory United States Date 14/01/23 URL https://www.mypanhandle.com/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl Title Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis Media name/outlet CBS17.com Country/Territory United States Date 14/01/23 URL https://www.cbs17.com/news/business/press-releases/globenewswire/8729858/arcutis-presents-new-phase-2-long-term-data-showing-sustained-efficacy-and-clearance-for-a-median-of-10-months-with-roflumilast-cream-in-adults-with-chronic-plaque-psoriasis/ Persons Mark Lebwohl